0000-00-00 |
|
|
|
External link to document |
2019-01-23 |
1 |
Complaint |
United States Patent Nos. 10,155,039 (“the
’039 patent”), 10,159,732 (“the ’732 patent”), and 10,159,…and continues to infringe the ’039 patent, ’732 patent, and ’733 patent;
B) A judgment permanently…further infringement of the ’039 patent, ’732 patent, and
’733 patent;
C) A judgment awarding…Amgen’s infringement of the ’039 patent, ’732 patent,
and ’733 patent was deliberate and willful;
…10,159,733 (“the ’733 patent”) under the Patent
Laws of the United States, 35 U.S.C. § 1 et seq.
|
External link to document |
2019-06-24 |
18 |
Answer to Counterclaim |
The Patents-In-Suit
112. U.S. Patent No. 10,155,039 (“the ’039 patent”), titled “Stable…Non-Infringement and Invalidity of U.S. Patent No. 10,155,039
117. Amgen restates and incorporates… U.S. Patent No. 9,114,166
(the “’166 patent”), U.S. Patent No. 8,916,157 (the “’157 patent”), and…Asserted Patents, for example, U.S. Patent No.
9,272,041 (the “’041 patent”) and U.S. Patent No. …and ’714 patents are
more relevant than the ’166 patent, the ’157 patent, and the ’583 patent to the |
External link to document |
2019-01-23 |
3 |
Patent/Trademark Report to Commissioner |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,155,039; US 10,159,732; US…
26 November 2019
1:19-cv-00139
830 Patent
Plaintiff
District Court, D. Delaware |
External link to document |